|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/4985 | (2006.01) |
| A61K 31/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| G01N 33/48 | (2006.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61K 31/5377 | (2006.01) | ||
| A61K 31/53 | (2006.01) | ||
| A61K 31/4745 | (2006.01) | ||
| A61K 31/47 | (2006.01) | ||
| A61K 31/4545 | (2006.01) | ||
| G01N 33/574 | (2006.01) | ||
| C12Q 1/6886 | (2018.01) |
| (11) | Number of the document | 3515418 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17777211.8 |
| Date of filing the European patent application | 2017-09-21 | |
| (97) | Date of publication of the European application | 2019-07-31 |
| (45) | Date of publication and mention of the grant of the patent | 2021-04-14 |
| (46) | Date of publication of the claims translation | 2021-07-26 |
| (86) | Number | PCT/EP2017/073894 |
| Date | 2017-09-21 |
| (87) | Number | WO 2018/055029 |
| Date | 2018-03-29 |
| (30) | Number | Date | Country code |
| 201616116 | 2016-09-22 | GB |
| (72) |
FRIGAULT, Melanie Mae, US
|
| (73) |
Astrazeneca AB,
151 85 Södertälje,
SE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Panaudojimas c-Met inhibitorių, skirtų vėžio su MET mutacijomis |
| USE OF C-MET INHIBITORS TO TREAT CANCERS HARBOURING MET MUTATIONS |
| Payment date | Validity (years) | Amount | |
| 2025-08-20 | 9 | 208.00 EUR |
| 2026-09-21 |